Market Research Report
Obesity Treatment Market with COVID-19 Impact Analysis, By Surgery, By Drugs, By End User, and By Region - Size, Share, & Forecast from 2021-2027
|Obesity Treatment Market with COVID-19 Impact Analysis, By Surgery, By Drugs, By End User, and By Region - Size, Share, & Forecast from 2021-2027|
Published: March 1, 2021
AnalystView Market Insights
Content info: 300 Pages
Delivery time: 2-3 business days
The global obesity treatment market was valued at USD 7.63 billion in 2020, growing with 16.3% CAGR during the forecast period, 2021-2027.
Obesity is a kind of disease caused due to extreme body fat content. The key factors determining the existence & the severity of obesity are body mass index, waist circumference, waist-to-height ratio, and other degenerative health conditions.
The obesity treatment market is estimated to witness significant growth in the next few years, owing to the rising adoption of advanced technology & adoption of minimally invasive procedures. In addition, the growing awareness about bariatric surgeries is also projected to boost the market growth. According to the Institute of Health Metrics and Evaluation, around 2.1 billion people which accounts for nearly 30.0% of the total world's population are either overweight or obese. In the middle- & low-income countries obesity is imposing a huge challenge. According to WHO data, obesity or obese conditions leads to various disorders that contribute to a greater mortality rate.
Several medical problems, genetics, inactivity, family lifestyle, medications, age, unhealthy diet, and pregnancy may lead to obesity. Moreover, obese conditions increase the risk of heart disease, diabetes, stroke, arthritis, and cancers. Obesity treatment is incorporated in two steps such as assessment & management. The obesity assessment involves the determination of the level of obesity while obesity management includes the overall maintenance of body weight. Further, the supportive government initiatives about creating awareness regarding fitness & health, and technological development is expected to positively impact market growth.
The obesity treatment market is differentiated into surgery, drugs, and end-user segments. Based on the surgery, the endoscopic procedures segment held the largest market share in 2019. By drugs, the malabsorption segment is anticipated to offer ample growth opportunities for the market.
North America dominated the global market with market share in 2019. The rising obese population and overweight concerns are driving the market growth. In addition, the growing prevalence of diabetes and hypertension is projected to contribute to market growth. Europe is the second-largest market in 2019. On the other side, Asia Pacific is estimated to grow at the highest CAGR over the forecast period. The increasing awareness levels across the developing countries and growing demand for bariatric surgeries is projected to bolster the market growth.
The obesity treatment market is moderately competitive in nature with the presence of domestic players and global players. Key companies in the industry mainly focus on strategic innovation, mergers & acquisition activities, product expansion to remain competent in the market. Top players in the market including Arena Pharmaceuticals, Inc., VIVUS, Inc., F. Hoffmann-La Roche Ltd., Medtronic, Novo Nordisk A/S, Allergan Plc, are holding the majority of the market share. In addition, several players focus on investment in R&D to develop new safety & drug products.
Key features of the study:
This proposed research study on Obesity Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Obesity Treatment market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Obesity Treatment market
Impact of COVID-19 on Obesity Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Obesity Treatment market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Obesity Treatment market, we have also included competitive landscape and key innovator analysis for the Obesity Treatment market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Obesity Treatment market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Obesity Treatment market on global as well as regional level.
The global Obesity Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL OBESITY TREATMENT MARKET KEY PLAYERS
F. Hoffmann-La Roche, Ltd.
Johnson & Johnson Services, Inc.
Novo Nordisk A/S
Arena Pharmaceuticals, Inc.
Orexigen Therapeutics, Inc.
USGI Medical, Inc.
Mediflex Surgical Products
GLOBAL OBESITY TREATMENT MARKET, BY SURGERY
Adjusting gastric Banding
Roux-en-Y Gastric Bypass
Biliopancreatic diversion with Duodenal Switch
GLOBAL OBESITY TREATMENT MARKET, BY DRUGS
GLOBAL OBESITY TREATMENT MARKET, BY END USER
GLOBAL OBESITY TREATMENT MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA
List of Tables
List of Figures